Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,833 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group.
Takashima S, Saeki T, Adachi I, Watanabe T, Sasaki Y, Murai H, Tabei T, Ogita M, Sano M, Kanda K, Shimoyama M. Takashima S, et al. Among authors: watanabe t. Jpn J Clin Oncol. 1997 Oct;27(5):325-30. doi: 10.1093/jjco/27.5.325. Jpn J Clin Oncol. 1997. PMID: 9390210 Clinical Trial.
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802).
Katsumata N, Watanabe T, Minami H, Aogi K, Tabei T, Sano M, Masuda N, Andoh J, Ikeda T, Shibata T, Takashima S. Katsumata N, et al. Among authors: watanabe t. Ann Oncol. 2009 Jul;20(7):1210-5. doi: 10.1093/annonc/mdn781. Epub 2009 Mar 2. Ann Oncol. 2009. PMID: 19254942 Free article. Clinical Trial.
A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.
Ando M, Watanabe T, Sasaki Y, Ying DF, Omuro Y, Katsumata N, Narabayashi M, Tokue Y, Fujii H, Igarashi T, Wakita H, Ohtsu T, Itoh K, Adachi I, Taguchi T. Ando M, et al. Among authors: watanabe t. Br J Cancer. 1998 Jun;77(11):1937-43. doi: 10.1038/bjc.1998.321. Br J Cancer. 1998. PMID: 9667671 Free PMC article. Clinical Trial.
Phase II study of paclitaxel (BMS-181339) intravenously infused over 3 hours for advanced or metastatic breast cancer in Japan. BMS-181339 Breast Cancer Study Group.
Ito Y, Horikoshi N, Watanabe T, Sasaki Y, Tominaga T, Okawa T, Tabei T, Kuraishi Y, Tamura K, Abe R, Kitajima M, Yamaguchi S, Kobayashi T, Koyama H, Orita K, Takashima S, Nomura Y, Ogawa M. Ito Y, et al. Among authors: watanabe t. Invest New Drugs. 1998;16(2):183-90. doi: 10.1023/a:1006036923200. Invest New Drugs. 1998. PMID: 9848584 Clinical Trial.
15,833 results
You have reached the last available page of results. Please see the User Guide for more information.